Logo image of ACAN.PA

ACANTHE DEVELOPPEMENT SA (ACAN.PA) Stock Fundamental Analysis

Europe - EPA:ACAN - FR0000064602 - REIT

0.308 EUR
+0.01 (+2.33%)
Last: 9/12/2025, 3:00:56 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ACAN. ACAN was compared to 42 industry peers in the Diversified REITs industry. While ACAN has a great health rating, there are worries on its profitability. ACAN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACAN had negative earnings in the past year.
ACAN had a positive operating cash flow in the past year.
In multiple years ACAN reported negative net income over the last 5 years.
Of the past 5 years ACAN 4 years had a positive operating cash flow.
ACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

ACAN's Return On Assets of -2.99% is on the low side compared to the rest of the industry. ACAN is outperformed by 83.33% of its industry peers.
ACAN's Return On Equity of -3.54% is on the low side compared to the rest of the industry. ACAN is outperformed by 78.57% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.54%, ACAN is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -2.99%
ROE -3.54%
ROIC 0.54%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ACAN.PA Yearly ROA, ROE, ROICACAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

ACAN's Operating Margin of 23.36% is on the low side compared to the rest of the industry. ACAN is outperformed by 78.57% of its industry peers.
In the last couple of years the Operating Margin of ACAN has grown nicely.
ACAN has a Gross Margin (73.83%) which is comparable to the rest of the industry.
ACAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.36%
PM (TTM) N/A
GM 73.83%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
ACAN.PA Yearly Profit, Operating, Gross MarginsACAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

7

2. Health

2.1 Basic Checks

ACAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ACAN has been increased compared to 1 year ago.
ACAN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACAN has a worse debt to assets ratio.
ACAN.PA Yearly Shares OutstandingACAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACAN.PA Yearly Total Debt VS Total AssetsACAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ACAN has an Altman-Z score of 2.53. This is not the best score and indicates that ACAN is in the grey zone with still only limited risk for bankruptcy at the moment.
ACAN has a better Altman-Z score (2.53) than 100.00% of its industry peers.
The Debt to FCF ratio of ACAN is 0.87, which is an excellent value as it means it would take ACAN, only 0.87 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACAN (0.87) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ACAN is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.01, ACAN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.87
Altman-Z 2.53
ROIC/WACC0.07
WACC7.78%
ACAN.PA Yearly LT Debt VS Equity VS FCFACAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.11 indicates that ACAN has no problem at all paying its short term obligations.
ACAN's Current ratio of 2.11 is amongst the best of the industry. ACAN outperforms 95.24% of its industry peers.
A Quick Ratio of 2.11 indicates that ACAN has no problem at all paying its short term obligations.
ACAN has a Quick ratio of 2.11. This is amongst the best in the industry. ACAN outperforms 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ACAN.PA Yearly Current Assets VS Current LiabilitesACAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.08% over the past year.
Looking at the last year, ACAN shows a decrease in Revenue. The Revenue has decreased by -1.16% in the last year.
Measured over the past years, ACAN shows a decrease in Revenue. The Revenue has been decreasing by -6.49% on average per year.
EPS 1Y (TTM)66.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.35%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-1.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAN.PA Yearly Revenue VS EstimatesACAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACAN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACAN.PA Price Earnings VS Forward Price EarningsACAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ACAN is valued a bit more expensive than the industry average as 78.57% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 35.22
EV/EBITDA N/A
ACAN.PA Per share dataACAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACAN!.
Industry RankSector Rank
Dividend Yield N/A

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (9/12/2025, 3:00:56 PM)

0.308

+0.01 (+2.33%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-23 2025-04-23
Earnings (Next)09-22 2025-09-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners49.25%
Ins Owner ChangeN/A
Market Cap50.93M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-46.74%
DP-70.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.99
P/FCF 35.22
P/OCF 33.64
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY2.84%
OCF(TTM)0.01
OCFY2.97%
SpS0.02
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -3.54%
ROCE 0.74%
ROIC 0.54%
ROICexc 0.57%
ROICexgc 0.57%
OM 23.36%
PM (TTM) N/A
GM 73.83%
FCFM 36.88%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y110.88%
ROICexc growth 3YN/A
ROICexc growth 5Y110.88%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.87
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 2.53
F-Score5
WACC7.78%
ROIC/WACC0.07
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.26%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-1.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y110.94%
EBIT growth 3YN/A
EBIT growth 5Y93.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.58%
FCF growth 3YN/A
FCF growth 5Y20.72%
OCF growth 1Y-65.3%
OCF growth 3YN/A
OCF growth 5Y-16.48%